新型冠状病毒感染大流行中风湿病共病患者的管理和疫苗接种特点

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

本文综述了一种新型冠状病毒感染（COVID-19）在免疫性风湿性疾病患者中的科学研究结果。在既定因素加剧其病程的情况下，这类患者感染冠状病毒的风险可能略高于人群风险（老年、肥胖、糖尿病、心血管疾病）。接受免疫抑制治疗和高剂量糖皮质激素的患者，可能会经历较长时间的阳性病毒复制和活病毒分离，因此需要动态监测和纠正抗风湿治疗。角膜后关节综合征可发生在病毒后关节炎的框架内，或首次出现免疫炎症性风湿病。文章介绍了全俄罗斯公共组织《俄罗斯风湿病学家协会》（«The Association of Rheumatologists of Russia»）的建议草案和The V.A. Nasonova Research Institute of Rheumatology关于COVID-19大流行条件下风湿病患者管理和疫苗接种的临时建议。

作者简介

Irina Belyaeva

North-Western State Medical University named after I.I. Mechnikov; Сlinical Rheumatology Hospital No. 25

Email: belib@mail.ru
ORCID iD: 0000-0002-7981-6349
SPIN 代码: 3136-9062

MD, Dr. Sci. (Med.), Assistant Professor

俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015; Saint Petersburg

Vadim Mazurov

North-Western State Medical University named after I.I. Mechnikov; Сlinical Rheumatology Hospital No. 25

Email: maz.nwgmu@yandex.ru
ORCID iD: 0000-0002-0797-2051
SPIN 代码: 6823-5482
Scopus 作者 ID: 16936315400
Researcher ID: J-9643-2014

MD, Dr. Sci. (Med.), Professor, Honoured Science Worker, Academician of the RAS

俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015; Saint Petersburg

Lyubov Sarantseva

North-Western State Medical University named after I.I. Mechnikov; Сlinical Rheumatology Hospital No. 25

Email: dr.liubovs@gmail.com
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015; Saint Petersburg

Evgeny Trofimov

North-Western State Medical University named after I.I. Mechnikov

编辑信件的主要联系方式.
Email: evgeniy.trofimov@szgmu.ru
SPIN 代码: 4358-1663

MD, Cand. Sci. (Med.), Assistant Professor

俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015

参考

  1. Belov BS, Muravyova NV, Tarasova GM. COVID-19: Rheumatological aspects. Effective pharmacotherapy. 2020;16(16):18–25. doi: 10.33978/2307-3586-2020-16-16-18-25
  2. Nasonov EL. Rossiiskie klinicheskie rekomendatsii. Revmatologiya. Moscow; 2018. P. 113–141. (In Russ.)
  3. Richman DD, Whitley RJ, Hayden FG. Clinical Virology, 4th ed. Washington: ASM Press; 2016.
  4. Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8 Suppl(Suppl 1):S9–14. doi: 10.1046/j.1440-1843.2003.00518.x
  5. Middle East Respiratory Syndrome Coronavirus [Internet]. Available from: https://www.who.int/emergencies/mers-cov/en/. Accessed: Feb 16, 2020.
  6. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol. 2020;92(4):401–402. doi: 10.1002/jmv.25678
  7. Coronavirus disease 2019 (COVID-19) Situation Report–52 [Internet]. WHO. Available from: https://www.who.int/docs/default-source/coronaviruse/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_2. Accessed: Sep 11, 2021.
  8. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi: 10.1016/S0140-6736(20)30251-8
  9. Coronavirus disease (COVID-2019) situation reports. 2020 [Internet]. WHO. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed: Mar 5, 2020.
  10. Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronaviruses: the species and its virus – a statement of the Coronavirus Study Group. bioRvxiv. 2020. doi: 10.1101/2020.02.07.937862
  11. Joo YB, Lim YH, Kim KJ, et al. Respiratory viral infections and the risk of rheumatoid arthritis. Arthritis Res Ther. 2019;21(1):199. doi: 10.1186/s13075-019-1977-9
  12. Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol. 2020;92(4):424–432. doi: 10.1002/jmv.25685
  13. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
  14. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. doi: 10.1007/s00134-020-05991-x
  15. Monti S, Balduzzi S, Delvino P, et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann. Rheum. Dis. 2020;79(5):667–668. doi: 10.1136/annrheumdis-2020-217424
  16. Tomelleri A, Sartorelli S, Campochiaro C, et al. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey. Ann Rheum Dis. 2020;79(9):1252–1253. doi: 10.1136/annrheumdis-2020-217600
  17. Del Manso M, Andrianou X, Urdiales AM, et al. Integrated surveillance of COVID-19 in Italy outputs and related activities. Epidemiol Prev. 2020;44(5–6 Suppl 2):70–80. (In Italian). doi: 10.19191/EP20.5-6.S2.105
  18. Polyanskaya MV. Pnevmoniya u patsientov s revmaticheskimi zabolevaniyami: chastota vstrechaemosti, klinicheskaya kartina, faktory riska [disseretation]. Moscow; 2009. (In Russ.)
  19. Karateev AE, Amirdzhanova VN, Nasonov EL, et al. “Post-COVID syndrome”: The focus is on musculoskeletal pain. Rheumatology Science and Practice. 2021;59(3):255–262. (In Russ.). doi: 10.47360/1995-4484-2021-255-262
  20. Mazurov VI, Belyaeva IB, Sarantseva LE, et al. Impact of a new coronavirus infection on the clinical course of immunoinflammatory rheumatic diseases. North-West State Medical University named after I.I. Mechnikov. 2021;13(2):39–47. (In Russ.). doi: 10.17816/mechnikov72269
  21. Gasparotto M, Framba V, Piovella C, et al. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40(8):3357–3362. doi: 10.1007/s10067-020-05550-1
  22. Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al. Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis. 2021;annrheumdis-2021-219859. doi: 10.1136/annrheumdis-2021-219859
  23. Fragata I, Mourão AF. Coronavirus Disease 19 (COVID-19) complicated with post-viral arthritis. Acta Reumatol Port. 2020;45(4):278–280.
  24. Nasonov EL, Lila AM, Mazurov VI, et al. Koronavirusnaya bolezn’ 2019 (COVID-19) i immunovospalitel’nye (autoimmunnye) revmaticheskie zabolevaniya. Proekt rekomendatsii Obshcherossiiskoi obshchestvennoi organizatsii “Assotsiatsiya revmatologov Rossii” [Internet]. (In Russ.). Available from: https://rheumatolog.su/news/koronavirusnaya-bolezn-2019-COVID-19-i-immunovospalitelnye-autoimmunnye-revmaticheskie-zabolevaniya/. Accessed: Sep 25, 2021.
  25. O vaktsinatsii protiv SOVID-19 pri immunovospalitel’nykh revmaticheskikh zabolevaniyakh [Internet]. (In Russ.). Available from: https://rheumatolog.su/news/o-vakcinacii-protiv-sOVID-19-pri-immunovospalitelnyh-revmaticheskih-zabolevaniyah/. Accessed: Sep 25, 2021.

补充文件

附件文件
动作
1. JATS XML
下载
2. Fig. 2. Arthritis of small joints of the left hand (III, IV metacarpophalangeal; III, IV proximal interphalangeal joints). Involvement of surrounding soft tissues (own data)

下载 (176KB)
索引源数据
3. Fig. 3. Complete regression of all forms of joint syndrome in patients receiving aceclofenac 200 mg/day for 14 days (own data)

下载 (93KB)
索引源数据
4. 图1 COVID-19后关节综合征的演变方案（实际获得数据）IIRD — 免疫性炎症性风湿病 Fig. 1. The scheme of the evolution of the joint syndrome after COVID-19 (own data). IIRD — immuno-inflammatory rheumatic disease

下载 (242KB)
索引源数据

版权所有 © Belyaeva I., Mazurov V., Sarantseva L., Trofimov E., 2021

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).